Carl Fratter

3.1k total citations
47 papers, 1.3k citations indexed

About

Carl Fratter is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, Carl Fratter has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 27 papers in Clinical Biochemistry and 8 papers in Genetics. Recurrent topics in Carl Fratter's work include Mitochondrial Function and Pathology (30 papers), Metabolism and Genetic Disorders (27 papers) and ATP Synthase and ATPases Research (17 papers). Carl Fratter is often cited by papers focused on Mitochondrial Function and Pathology (30 papers), Metabolism and Genetic Disorders (27 papers) and ATP Synthase and ATPases Research (17 papers). Carl Fratter collaborates with scholars based in United Kingdom, United States and South Africa. Carl Fratter's co-authors include Joanna Poulton, A Seller, Michael G. Hanna, Shamima Rahman, Rajesh V. Thakker, Cathy E. Woodward, Mary G. Sweeney, Nicholas C.P. Cross, John F. Harvey and Helen White and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Brain.

In The Last Decade

Carl Fratter

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl Fratter United Kingdom 26 945 530 184 158 151 47 1.3k
S. Lane Rutledge United States 19 844 0.9× 519 1.0× 252 1.4× 104 0.7× 129 0.9× 31 1.3k
Judit García‐Villoria Spain 24 673 0.7× 511 1.0× 135 0.7× 189 1.2× 69 0.5× 73 1.3k
Brendan C. Lanpher United States 17 581 0.6× 259 0.5× 465 2.5× 109 0.7× 31 0.2× 41 1.2k
H. ter Laak Netherlands 19 634 0.7× 184 0.3× 93 0.5× 129 0.8× 42 0.3× 37 934
Mohammed Almannai Saudi Arabia 17 597 0.6× 381 0.7× 137 0.7× 125 0.8× 38 0.3× 43 935
H. Ogier de Baulny France 17 626 0.7× 808 1.5× 136 0.7× 274 1.7× 62 0.4× 33 1.2k
Barbara Celona United States 10 497 0.5× 319 0.6× 65 0.4× 81 0.5× 55 0.4× 13 976
Elena D’Amato Italy 13 408 0.4× 59 0.1× 486 2.6× 192 1.2× 126 0.8× 22 1.2k
Ying Jin China 15 258 0.3× 136 0.3× 210 1.1× 56 0.4× 22 0.1× 52 865

Countries citing papers authored by Carl Fratter

Since Specialization
Citations

This map shows the geographic impact of Carl Fratter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Fratter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Fratter more than expected).

Fields of papers citing papers by Carl Fratter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Fratter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Fratter. The network helps show where Carl Fratter may publish in the future.

Co-authorship network of co-authors of Carl Fratter

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Fratter. A scholar is included among the top collaborators of Carl Fratter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Fratter. Carl Fratter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fratter, Carl, Will Lester, Charles Percy, et al.. (2025). The diagnostic utility of genetic testing in inherited thrombocytopenia: regional multicenter tertiary experience. Research and Practice in Thrombosis and Haemostasis. 9(3). 102869–102869.
2.
Dombi, Eszter, Val Millar, Janet Carver, et al.. (2024). Nucleoside supplements as treatments for mitochondrial DNA depletion syndrome. Frontiers in Cell and Developmental Biology. 12. 1260496–1260496. 5 indexed citations
3.
Huang, Xiaoping, Evelyn Fessler, Yan Li, et al.. (2022). OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathy. Journal of Clinical Investigation. 132(14). 41 indexed citations
4.
Fratter, Carl, Raymond Dalgleish, Stephanie Allen, et al.. (2020). EMQN best practice guidelines for genetic testing in dystrophinopathies. European Journal of Human Genetics. 28(9). 1141–1159. 39 indexed citations
5.
Hardy, Steven, Emma L. Blakely, Sila Hopton, et al.. (2017). Pigmentary retinopathy, rod–cone dysfunction and sensorineural deafness associated with a rare mitochondrial tRNALys(m.8340G>A) gene variant. British Journal of Ophthalmology. 101(9). 1298–1302. 6 indexed citations
6.
Ng, Yi Shiau, Steven Hardy, Gerardine Quaghebeur, et al.. (2016). Clinical features of the pathogenic m.5540G>A mitochondrial transfer RNA tryptophan gene mutation. Neuromuscular Disorders. 26(10). 702–705. 5 indexed citations
8.
Nesbitt, Victoria, Charlotte L. Alston, Emma L. Blakely, et al.. (2014). A national perspective on prenatal testing for mitochondrial disease. European Journal of Human Genetics. 22(11). 1255–1259. 43 indexed citations
9.
Horga, Alejandro, Robert D. S. Pitceathly, Julian Blake, et al.. (2014). Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia. Brain. 137(12). 3200–3212. 27 indexed citations
10.
Chapman, Thomas, Gina Hadley, Carl Fratter, et al.. (2013). Unexplained gastrointestinal symptoms: Think mitochondrial disease. Digestive and Liver Disease. 46(1). 1–8. 25 indexed citations
11.
Pitceathly, Robert D. S., Susan E Tomlinson, Iain P. Hargreaves, et al.. (2012). Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase γ mutations. Journal of Neurology Neurosurgery & Psychiatry. 84(1). 107–110. 13 indexed citations
12.
Pitceathly, Robert D. S., Elisa Fassone, Jan‐Willem Taanman, et al.. (2011). Kearns–Sayre syndrome caused by defective R1/p53R2 assembly. Journal of Medical Genetics. 48(9). 610–617. 28 indexed citations
13.
Anand, Geetha, et al.. (2010). X‐linked hereditary motor sensory neuropathy (type 1) presenting with a stroke‐like episode. Developmental Medicine & Child Neurology. 52(7). 677–679. 33 indexed citations
14.
Marchington, Jackie, Sohail Malik, Anita Banerjee, et al.. (2009). Information for genetic management of mtDNA disease: sampling pathogenic mtDNA mutants in the human germline and in placenta. Journal of Medical Genetics. 47(4). 257–261. 27 indexed citations
15.
Ashley, Neil, Sandeep Jayawant, Jeremy Parr, et al.. (2007). Mutations in the mitochondrial DNA gamma polymerase (POLG-G) may cause Alpers syndrome, mitochondrial DNA depletion and apparent non-syndromic status epilepticus: implications for valproate therapy. Journal of Medical Genetics. 44. 1 indexed citations
16.
Fratter, Carl, A O'Rourke, Jackie Marchington, et al.. (2006). Molecular genetic diagnosis of mitochondrial DNA depletion syndrome and Alpers syndrome. Journal of Medical Genetics. 43. 1 indexed citations
17.
Bradley, Karin, Branca Cavaco, Michael R. Bowl, et al.. (2006). Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clinical Endocrinology. 64(3). 299–306. 83 indexed citations
18.
White, Helen, et al.. (2005). Accurate Detection and Quantitation of Heteroplasmic Mitochondrial Point Mutations by Pyrosequencing. Genetic Testing. 9(3). 190–199. 91 indexed citations
19.
Seller, A, et al.. (2004). Detection and estimation of heteroplasmy for mitochondrial mutations using NanoChip and Pyrosequencing technology. ePrints Soton (University of Southampton). 1 indexed citations
20.
Poulton, Joanna, et al.. (2001). Progress in genetic counselling and prenatal diagnosis of maternally inherited mtDNA diseases. Journal of Medical Genetics. 38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026